Healthcare professional injecting a patient in the chin with 0.8 cc of juvéderm® voluma¿ xc and in the lip with 0.7 cc of juvéderm® ultra.The patient experienced a ¿possible occlusion¿ at the injection site the next day.Patient was treated with 6 vials of hylenex, 3 in the chin and 3 in the lips.The next day, the patient was treated with 2 vials of hylenex, 1 in the chin and 1 in the lips.The event resolved that day with no permanent damaged.This is the same event and the same patient reported under mdr id# 3005113652-2023-00165 (allergan complaint #(b)(4).This mdr is being submitted for the suspect product, juvéderm® ultra.
|